Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand
2024

Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand

Sample size: 223 publication 10 minutes Evidence: moderate

Author Information

Author(s): Sathitruangsak Chirawadee, Pattarapuntakul Tanawat, Kaewdech Apichat, Thongkan Tortrakoon, Prisutkul Apinya, Thongwatchara Phatcharaporn, Sriplung Hutcha, Kongkamol Chanon, Kanokwiroon Kanyanatt, Obchoei Sumalee, Sripongpun Pimsiri

Primary Institution: Faculty of Medicine, Prince of Songkla University

Hypothesis

This study aimed to analyze the clinical characteristics and outcomes of CCA patients in Southern Thailand.

Conclusion

Most patients were diagnosed late, and the median overall survival was only 5–6 months, with better survival rates for unresectable CCA patients receiving systemic chemotherapy and palliative biliary drainage.

Supporting Evidence

  • 59.4% of patients were diagnosed at TMN stage IV.
  • Only 15.1% of the cohort were deemed resectable.
  • The median overall survival for iCCA, pCCA, and dCCA patients were 27.3, 22.0, and 19.3 weeks, respectively.
  • One-year survival rate differed significantly between resectable and unresectable patients (85.2% vs. 21.2%).
  • TMN stage, palliative biliary drainage, and systemic chemotherapy were independent predictors for mortality in unresectable cholangiocarcinoma.

Takeaway

Cholangiocarcinoma patients in Southern Thailand often find out they have cancer too late, but those who get certain treatments can live longer.

Methodology

The study retrospectively reviewed 223 patients diagnosed with CCA between 2018 and 2021, analyzing clinicopathologic data and survival outcomes using Kaplan–Meier and Cox regression methods.

Potential Biases

Potential biases due to the retrospective nature of the study and missing data on certain variables.

Limitations

The study is retrospective, which may lead to missing information, and it lacks a control group to confirm the relationship between CCA and predisposing factors.

Participant Demographics

The mean age was 63.9 years, with 50.7% men; most patients were diagnosed at advanced stages.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI: 49–54 months

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1002/cam4.70491

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication